Wednesday, October 24, 2007

GlaxoSmithKline to slash costs, jobs as profits drop (AFP)

The GlaxoSmithKline headquarters compound in west London. British pharmaceutical giant GlaxoSmithKline said it would cut jobs and costs as it blamed a fall in third-quarter profits on sliding sales of controversial diabetes drug Avandia.(AFP/File/Odd Andersen)AFP - British pharmaceutical giant GlaxoSmithKline said Wednesday it would cut jobs and costs as it blamed a fall in third-quarter profits on sliding sales of controversial diabetes drug Avandia.


No comments: